(IMCD) IMCD - Ratings and Ratios
Exchange: AS •
Country: Netherlands •
Currency: EUR •
Type: Common Stock •
ISIN: NL0010801007
Chemicals, Additives, Ingredients, Lubricants, Solvents
Dividends
| Dividend Yield | 2.81% |
| Yield on Cost 5y | 2.26% |
| Yield CAGR 5y | 5.62% |
| Payout Consistency | 95.1% |
| Payout Ratio | 39.0% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 25.9% |
| Value at Risk 5%th | 39.6% |
| Relative Tail Risk | -7.09% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -2.06 |
| Alpha | -53.22 |
| CAGR/Max DD | -0.29 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.530 |
| Beta | 0.214 |
| Beta Downside | 0.176 |
| Drawdowns 3y | |
|---|---|
| Max DD | 53.94% |
| Mean DD | 17.66% |
| Median DD | 14.33% |
Description: IMCD IMCD November 07, 2025
IMCD N.V. is a Rotterdam-based global distributor of specialty chemicals and ingredients, serving customers across Europe, the Middle East, Africa, the Americas and Asia-Pacific. Its portfolio spans adhesives, flame retardants, pigments, polymers, surfactants, UV filters, lubricants, fuel additives and a wide array of functional additives for plastics, coatings, personal-care, and oil-&-gas markets.
According to the FY 2023 results (released in early 2024), IMCD generated €6.2 billion of revenue with an adjusted EBITDA margin of roughly 13%, reflecting the high-value, low-inventory nature of specialty-chemical distribution. Growth is being driven primarily by rising demand for lightweight automotive polymers and sustainable packaging solutions-sectors that historically grow at 4-5 % CAGR and benefit from regulatory pressure on emissions. However, the business remains exposed to macro-economic cycles and raw-material price volatility, which can compress margins in downturns.
If you want a data-rich, side-by-side comparison of IMCD’s cash-flow dynamics and peer multiples, the ValueRay platform offers a concise, quantitative deep-dive that can help you assess the investment case more rigorously.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (292.3m TTM) > 0 and > 6% of Revenue (6% = 266.6m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA -10.13pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 17.94% (prev 15.85%; Δ 2.09pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 248.1m <= Net Income 292.3m (YES >=105%, WARN >=100%) |
| Net Debt (1.09b) to EBITDA (545.4m) ratio: 2.01 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.75 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (59.0m) change vs 12m ago 3.41% (target <= -2.0% for YES) |
| Gross Margin 11.65% (prev 11.97%; Δ -0.32pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 101.2% (prev 110.8%; Δ -9.57pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 8.70 (EBITDA TTM 545.4m / Interest Expense TTM 49.6m) >= 6 (WARN >= 3) |
Altman Z'' 2.80
| (A) 0.17 = (Total Current Assets 1.86b - Total Current Liabilities 1.07b) / Total Assets 4.63b |
| (B) 0.20 = Retained Earnings (Balance) 915.6m / Total Assets 4.63b |
| (C) 0.10 = EBIT TTM 431.2m / Avg Total Assets 4.39b |
| (D) 0.35 = Book Value of Equity 915.6m / Total Liabilities 2.65b |
| Total Rating: 2.80 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 70.78
| 1. Piotroski 4.0pt |
| 2. FCF Yield 3.73% |
| 3. FCF Margin 5.04% |
| 4. Debt/Equity 0.82 |
| 5. Debt/Ebitda 2.01 |
| 6. ROIC - WACC (= 7.21)% |
| 7. RoE 15.25% |
| 8. Rev. Trend 85.05% |
| 9. EPS Trend -3.36% |
What is the price of IMCD shares?
As of December 06, 2025, the stock is trading at EUR 76.60 with a total of 261,848 shares traded.
Over the past week, the price has changed by -0.88%, over one month by -13.72%, over three months by -17.47% and over the past year by -45.14%.
Over the past week, the price has changed by -0.88%, over one month by -13.72%, over three months by -17.47% and over the past year by -45.14%.
Is IMCD a buy, sell or hold?
IMCD has no consensus analysts rating.
What are the forecasts/targets for the IMCD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 130.6 | 70.5% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 71 | -7.3% |
IMCD Fundamental Data Overview November 25, 2025
Market Cap USD = 5.34b (4.58b EUR * 1.1666 EUR.USD)
Market Cap EUR = 4.58b (4.58b EUR * 1.0 EUR.EUR)
P/E Trailing = 16.9584
P/E Forward = 12.1212
P/S = 0.9462
P/B = 2.3159
Beta = 1.193
Revenue TTM = 4.44b EUR
EBIT TTM = 431.2m EUR
EBITDA TTM = 545.4m EUR
Long Term Debt = 1.32b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 299.9m EUR (from shortLongTermDebt, last fiscal year)
Debt = 1.62b EUR (Calculated: Short Term 299.9m + Long Term 1.32b)
Net Debt = 1.09b EUR (from netDebt column, last fiscal year)
Enterprise Value = 6.00b EUR (4.58b + Debt 1.62b - CCE 190.4m)
Interest Coverage Ratio = 8.70 (Ebit TTM 431.2m / Interest Expense TTM 49.6m)
FCF Yield = 3.73% (FCF TTM 223.8m / Enterprise Value 6.00b)
FCF Margin = 5.04% (FCF TTM 223.8m / Revenue TTM 4.44b)
Net Margin = 6.58% (Net Income TTM 292.3m / Revenue TTM 4.44b)
Gross Margin = 11.65% ((Revenue TTM 4.44b - Cost of Revenue TTM 3.93b) / Revenue TTM)
Gross Margin QoQ = none% (prev 10.77%)
Tobins Q-Ratio = 1.30 (Enterprise Value 6.00b / Total Assets 4.63b)
Interest Expense / Debt = 1.81% (Interest Expense 29.3m / Debt 1.62b)
Taxrate = 26.78% (101.8m / 380.0m)
NOPAT = 315.7m (EBIT 431.2m * (1 - 26.78%))
Current Ratio = 1.75 (Total Current Assets 1.86b / Total Current Liabilities 1.07b)
Debt / Equity = 0.82 (Debt 1.62b / totalStockholderEquity, last quarter 1.98b)
Debt / EBITDA = 2.01 (Net Debt 1.09b / EBITDA 545.4m)
Debt / FCF = 4.89 (Net Debt 1.09b / FCF TTM 223.8m)
Total Stockholder Equity = 1.92b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.32% (Net Income 292.3m / Total Assets 4.63b)
RoE = 15.25% (Net Income TTM 292.3m / Total Stockholder Equity 1.92b)
RoCE = 13.34% (EBIT 431.2m / Capital Employed (Equity 1.92b + L.T.Debt 1.32b))
RoIC = 12.59% (NOPAT 315.7m / Invested Capital 2.51b)
WACC = 5.38% (E(4.58b)/V(6.20b) * Re(6.81%) + D(1.62b)/V(6.20b) * Rd(1.81%) * (1-Tc(0.27)))
Discount Rate = 6.81% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 33.33 | Cagr: 0.12%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈383.0m ; Y1≈251.5m ; Y5≈115.0m
Fair Price DCF = 38.29 (DCF Value 2.26b / Shares Outstanding 59.0m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -3.36 | EPS CAGR: -14.08% | SUE: -2.33 | # QB: 0
Revenue Correlation: 85.05 | Revenue CAGR: 35.69% | SUE: -0.01 | # QB: 0
EPS next Year (2026-12-31): EPS=6.24 | Chg30d=-0.204 | Revisions Net=-3 | Growth EPS=+8.8% | Growth Revenue=+5.3%
Market Cap EUR = 4.58b (4.58b EUR * 1.0 EUR.EUR)
P/E Trailing = 16.9584
P/E Forward = 12.1212
P/S = 0.9462
P/B = 2.3159
Beta = 1.193
Revenue TTM = 4.44b EUR
EBIT TTM = 431.2m EUR
EBITDA TTM = 545.4m EUR
Long Term Debt = 1.32b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 299.9m EUR (from shortLongTermDebt, last fiscal year)
Debt = 1.62b EUR (Calculated: Short Term 299.9m + Long Term 1.32b)
Net Debt = 1.09b EUR (from netDebt column, last fiscal year)
Enterprise Value = 6.00b EUR (4.58b + Debt 1.62b - CCE 190.4m)
Interest Coverage Ratio = 8.70 (Ebit TTM 431.2m / Interest Expense TTM 49.6m)
FCF Yield = 3.73% (FCF TTM 223.8m / Enterprise Value 6.00b)
FCF Margin = 5.04% (FCF TTM 223.8m / Revenue TTM 4.44b)
Net Margin = 6.58% (Net Income TTM 292.3m / Revenue TTM 4.44b)
Gross Margin = 11.65% ((Revenue TTM 4.44b - Cost of Revenue TTM 3.93b) / Revenue TTM)
Gross Margin QoQ = none% (prev 10.77%)
Tobins Q-Ratio = 1.30 (Enterprise Value 6.00b / Total Assets 4.63b)
Interest Expense / Debt = 1.81% (Interest Expense 29.3m / Debt 1.62b)
Taxrate = 26.78% (101.8m / 380.0m)
NOPAT = 315.7m (EBIT 431.2m * (1 - 26.78%))
Current Ratio = 1.75 (Total Current Assets 1.86b / Total Current Liabilities 1.07b)
Debt / Equity = 0.82 (Debt 1.62b / totalStockholderEquity, last quarter 1.98b)
Debt / EBITDA = 2.01 (Net Debt 1.09b / EBITDA 545.4m)
Debt / FCF = 4.89 (Net Debt 1.09b / FCF TTM 223.8m)
Total Stockholder Equity = 1.92b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.32% (Net Income 292.3m / Total Assets 4.63b)
RoE = 15.25% (Net Income TTM 292.3m / Total Stockholder Equity 1.92b)
RoCE = 13.34% (EBIT 431.2m / Capital Employed (Equity 1.92b + L.T.Debt 1.32b))
RoIC = 12.59% (NOPAT 315.7m / Invested Capital 2.51b)
WACC = 5.38% (E(4.58b)/V(6.20b) * Re(6.81%) + D(1.62b)/V(6.20b) * Rd(1.81%) * (1-Tc(0.27)))
Discount Rate = 6.81% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 33.33 | Cagr: 0.12%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈383.0m ; Y1≈251.5m ; Y5≈115.0m
Fair Price DCF = 38.29 (DCF Value 2.26b / Shares Outstanding 59.0m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -3.36 | EPS CAGR: -14.08% | SUE: -2.33 | # QB: 0
Revenue Correlation: 85.05 | Revenue CAGR: 35.69% | SUE: -0.01 | # QB: 0
EPS next Year (2026-12-31): EPS=6.24 | Chg30d=-0.204 | Revisions Net=-3 | Growth EPS=+8.8% | Growth Revenue=+5.3%